CGM prescriptions remain strikingly low in federally qualified health centers, with significant racial, ethnic, and insurance-based disparities, according to new research.
These findings suggest that a shorter duration of antiplatelet therapy may be a safe and effective strategy for these patients, but further research is needed to confirm these findings and identify optimal patient subgroups.
In a recent study, researchers examined the impact of weight loss on specific types of bioactive lipids such as diacylglycerides and ceramides in skeletal muscles.
These investigators found huge never-fill rates for certain recommended cardiovascular medications among Medicare beneficiaries with T2D following hospitalization. What?